Tito Ortiz, MMA Superstar, Rekindles Relationship with Estranged Father

“I was waiting a long time for this day.” – Tito Ortiz

LOS ANGELES, CA, UNITED STATES, November 30, 2018 /EINPresswire.com/ — MMA superstar Tito Ortiz, who recently knocked out his opponent Chuck Lidell in their bout on November 24th, 2018, also managed to rekindle a relationship with his estranged father. The father of two had a difficult relationship with his father growing up, but the MMA legend revealed that things are moving in a positive direction in an Instagram post on his profile.

“I was waiting a long time for this day,” Tito writes, “I have had to go through a lot in my life to learn how to forgive. This has been well over 29 years overdue. This is about how drugs can ruin a father and son relationship but make the son so determined to change the cycle that’s all he could focus on.”

The reunion in November was the second time Ortiz had seen his father in 9 years. The last time, Ortiz’s father had come to him seeking to apologize for past actions, but Ortiz states that it hadn’t felt sincere, so he wasn’t quite ready to forgive. However, now that the fighter has also navigated the challenges of fatherhood, he understands how his father’s actions might’ve occurred.

“5 years ago, I went through the same thing that my Mom and Dad went through when I was 12 years old,” Ortiz elaborates, “after all these years I didn’t understand, but now I do as a father and someone who almost lost everything. I understand that he didn’t know better. You’re only as good as you know or only as good as you have learned.”

Things are finally on the mend, with Ortiz saying he is ready to break that cycle and fully forgive his father for his past actions. His reasoning? Ortiz believes that it is useless to hate someone that didn’t know better at the time, or couldn’t change. “For the first time in 29 years I told my Dad I love him and he said he loved me back. He said he was proud of me. I have always wanted to hear that from him,” Ortiz writes emotionally, “so thank you Dad. You have made your son very happy in many ways… It’s nice to have my Dad in my life again!”

Ortiz, who is the former UFC light heavyweight champion and a UFC Hall of Famer, returned to the cage opposite the fiercest rival of his career, Chuck Liddell on November 24th. The fight went down at The Forum in Inglewood in California, where Ortiz knocked out his opponent in the first round of their match. He has retired following the win, and will leave the sport on a two-fight win streak, winning four of his five bouts since leaving UFC back in 2012. As for what’s next for Tito, he plans on remaining in the fight game as a promoter.

Aurora DeRose
Aurora DeRose
+1 310-396-6090
email us here


Source: EIN Presswire

LIFESTART ANNOUNCES THEIR NEWEST LOCATION IN BOSTON

LifeStart is excited to announce their newest corporate location in Boston.

BOSTON, MA, USA, November 30, 2018 /EINPresswire.com/ — LifeStart is honored to be selected to provide a fun and innovative approach to corporate fitness center management, including engaging programming targeted at the entire employee population and integrated wellness services provided by specialized health professionals. The implementation of LifeStart’s specialized programs and services as well as the provision of more specialized health professionals, will help our client create a fun workplace culture that continues to thrive.

LifeStart uses the onsite fitness center as the Hub for health and well-being, and expands their offerings beyond typical fitness tasks. Instead the focus is on providing opportunities for employees to improve their health and well-being.

The onsite center is fully-staffed with an onsite Health Coach, RDLD, Exercise Professionals, and over 16 various group exercise classes per week.

LifeStart continues to expand their presence in the Northeast with more centers coming online in the next 30-days.

About LifeStart Wellness Network

Founded in 1991, LifeStart provides premium corporate fitness solutions to established companies and enterprises ranging from small business to Fortune 500 brands. The company has seen extraordinary growth over the past three years, now operating 80 sites in 13 states nationwide. LifeStart has more than 27 years of experience in designing, developing and operating hospitality-focused amenities for our nationwide customer base. As a service-driven company that believes in consistently delivering the best experience at work, our stunning, design-driven centers and best-in-class services install a sense of pride in our customers and empower our members to achieve their best each day. To learn more about LifeStart, visit www.lifestart.net.

Mike Flanagan
LifeStart
+1 312-627-1300
email us here


Source: EIN Presswire

Fucoidan (Mozuku, Mekabu & Fucus) may help prevent male human papillomavirus (HPV) by Dr. Susana Trujillo

Male human papillomavirus (HPV) infection significantly contributes to infection and subsequent cervical disease in women.

As the immune system is the first line of defense against HPV, boosting it can help fight off the virus naturally. Fucoidan has been shown to increase the likelihood of clearing HPV.”

— Dr. Susana Trujillo

NEW YORK, NY, UNITED STATES, November 30, 2018 /EINPresswire.com/ — Male human papillomavirus (HPV) infection significantly contributes to infection and subsequent cervical disease in women.1,9 Several studies of women with cervical cancer and their husbands have shown that men's sexual behavior affects women's risk of cervical neoplasia (neoplasia is a type of abnormal and excessive growth of tissue), even when controlling for female sexual activity. In areas with a high incidence of cervical cancer, men's sexual behavior is a risk factor for cervical neoplasia.2,3,10 More recently, studies have shown that HPV contributes to men's burden of diseases such prostate and oropharyngeal cancers and genital warts. Therefore, it is important to recognize the growing interest in understanding HPV infection in men and to learn about new alternative and natural ways to prevent it. Fucoidan, a natural polysaccharide obtained from brown seaweeds (Mozuku, Mekabu and Fucus), has demonstrated to have anti-HPV activities and can be used as an alternative for the prevention of HPV.

Fucoidan, particularly obtained from Mozuku, Mekabu and Fucus, is one of the most commonly used natural products with anti-HPV activities that can emerge as potential treatments for different types of cancer because it contains polysaccharides, phytochemicals and isolated active compounds.

As in the cervix, HPV can be found frequently in samples obtained from the anus and male genitals. Approximately 20% of men have HPV DNA detected in the anogenital (including coronal, shaft, scrotum and anal) area. This wide range is due in part to the difficulty in obtaining adequate samples from the genitals of men. 3,4,5 In men who have sex with men, the prevalence of anal HPV is much higher. The highest prevalence can be found in HIV-infected homosexual men with a prevalence of over 90% in the anus. Anal HPV infections are also common in adolescent and adult women with rates ranging from 13% to 50%. As in men, the highest prevalence of anal HPV in women is found in those who are HIV-infected.6,7

The most common risk associated with detection of HPV in the anogenital area in heterosexual men is the number of lifetime sexual partners. However, unlike women, older men are as likely as younger men to be HPV-infected. This is true whether the men are heterosexual or homosexual. The reasons for this difference may be that men do not develop adequate immune responses to maintain protection. Studies have shown that at all ages the antibody levels are lower for men than for women. Alternatively, men may be having more new sex partners than women.8,10

Fucoidan derived from brown seaweeds (Mozuku, Mekabu and Fucus) has shown to have a variety of bioactivities such as antitumor, antiviral, anticoagulant, antioxidant, immuno-inflammatory effects and other medicinal properties. The studies on the antiviral actions of Fucoidan are increasing interests in the research areas, particularly its anti-HPV properties. Fucoidan can either inhibit the replication of virus through interfering viral life cycle or improve the host antiviral immune responses to accelerate the process of viral clearance. The life cycle of viruses differs greatly between species but there are six basic stages in the life cycle of viruses: viral adsorption, viral penetration, uncoating of capsids, biosynthesis, viral assembly and viral release. Fucoidan can inhibit viral life cycle at different stages or directly inactivate virions before virus infection. Specific antiviral mechanism of Fucoidan is commonly related to specific structure features of the polysaccharide.

As the immune system is the first line of defense against HPV, boosting it can help fight off the virus naturally. Fucoidan has been shown to increase the likelihood of clearing HPV. The best Fucoidan is obtained from the brown seaweeds Mozuku, Mekabu and Fucus. It is suggested to take Fucoidan that includes beta-glucans to get the best results. In conclusion, Fucoidan, especially obtained from Mozuku, Mekabu and Fucus, has many advantages, such as broad spectrum of antiviral properties and low cytotoxicity, which suggest that Fucoidan is a promising antivirals extract that can be used alone or in combination with other ingredients like beta-glucans.

References:
1. Frenkl T, Potts J. Sexually transmitted diseases. In: Wein A. Campbell-Walsh Urology. Philadelphia, PA: Saunders; 2007 : 371-385.
2. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337(19):1350-1358.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
4. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288(14):1749-1757.
5. Schneider A, Kirchmayr R, De Villiers EM, Gissmann L. Subclinical human papillomavirus infection in male sexual partners of female carriers. J Urol. 1988;140(6):1431-1434.
6. Centers for Disease Control and Prevention. HPV and men. CDC Fact Sheet. http://www.cdc.gov/std/HPV/STDFact-HPV-and-men.htm. Accessed September 5, 2009.
7. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194(8):1044-1057.

Dr. Susana Trujillo
Dr. Susana Trujillo
+1 929-215-4079
email us here


Source: EIN Presswire

Fucoidan (Mozuku, Mekabu & Fucus) may help prevent human papillomavirus (HPV) in adolescents by Dr. Susana Trujillo

Human papillomavirus (HPV) infects about 14 million people, including teens, each year.

Fucoidan’s anti-HPV and anti-cancer properties have the potential to treat both unapparent HPV infection as well as visible clinical diseases. ”

— Dr. Susana Trujillo

NEW YORK, NEW YORK, UNITED STATES, November 30, 2018 /EINPresswire.com/ — Human papillomavirus (HPV) infects about 14 million people, including teens, each year. While most HPV infections go away on their own, infections that don’t go away can lead to certain types of cancer. Every year, 32,500 men and women develop a cancer caused by HPV. HPV vaccination could prevent more than 90% of these cancers from ever developing. 1 Still, it is important to note that there are natural alternatives that have been shown to prevent HPV. One of these innovative natural ingredients is known as Fucoidan and it is mainly obtained from the brown seaweeds Mozuku, Mekabu and Fucus.

Human papillomavirus (HPV) vaccination can lead to substantial reductions in the incidence of HPV infection and HPV-related diseases, including anogenital cancers and genital warts. The introduction of the HPV vaccine in 2006 and the subsequent use of the vaccine in 2008 created opportunities to counter the existing HPV disease burden.2 Given the high rates of HPV infection that occur shortly after the initiation of sex and the vaccine's ability to prevent infection only prior to exposure, HPV vaccination has been particularly targeted to young adolescents. Routine vaccination with either the vaccine has been recommended by the Centers for Disease Control and Prevention's (CDC's) Advisory Committee for Immunization Practices (ACIP) for adolescent females ages 11-12, with catch-up vaccination for young women 13-26 years of age. However, years after the vaccine was introduced, at least half of the target population of adolescent females had not initiated HPV vaccination.9

The CDC reported that many adolescents do not get vaccinated because of lack of HPV knowledge, perception of daughter's risk for HPV acquisition, belief in vaccination benefits, degree of concern about vaccine side effects, child's age, social influences, concern regarding post-vaccination sexual disinhibition, physician's recommendation, and parent's personal exposure to HPV infection.3,4 Considering the morbidity and mortality associated with HPV disease as well as the disproportionately high HPV disease burden in minority and uninsured women within the United States, it is crucial that we continue to provide new options available for adolescents to protect their body from HPV infections.6 Therefore, it is essential to find new alternatives that can provide adolescents a natural option, like Fucoidan, for them to prevent HPV and to enhance their immune system to fight the infection.8

Current research for natural products to be applied in medicine and to promote health has put some emphasis in research on brown seaweeds like Fucoidan. Extensive literature on the health benefits of Fucoidan and its uses has been published since the last decade. However, comparatively, there are only a handful of research papers on Fucoidan and its anti-HPV function. Still, all these studies related to Fucoidan and its anti-HPV properties is very promising.
Fucoidan from brown seaweeds possess good antiviral and anti-tumor activities and some of them have been developed into novel antiviral agents. Fucoidan is a term used to define polysaccharides containing l-fucose found in brown seaweed (Mozuku, Mekabu and Fucus) and the structures of Fucoidan may vary among species and sometimes among different parts of the seaweed. In studies, Fucoidan showed significant anti-cancer and anti-HPV properties.

HPV vaccination provides a strong potential to improve public health by decreasing HPV–related anogenital cancers and genital warts. Despite the increase in vaccination rates, half of the target population continues to remain unvaccinated and completion rates lag in those populations that are at highest risk for HPV disease morbidity. However, improved understanding of the reasons chosen for non-vaccination, including vaccine safety and provider non-recommendation may delay the effort for increase in vaccination rates. Recognizing that timing of HPV vaccination is important and it is recommended prior to sexual exposure, continued alternatives are highly needed to help adolescents prevent additional diseases like cancer.7 It is important to educate adolescents about the importance of having a strong immune system. According to the CDC, the body's immune system clears HPV from 90 percent of individuals who have it within two years. Keeping your immune system healthy can aid the body in getting rid of HPV and Fucoidan is one of the best options to enhance it.9

In summary, Fucoidan’s anti-HPV and anti-cancer properties have the potential to treat both unapparent HPV infection as well as visible clinical diseases. Besides that, Fucoidan has many advantages, such as low toxicity, convenience to ingest and bioavailability, which suggests that Fucoidan may reduce or regulate HPV infection and related cancers.

References:

1. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(suppl 5): F12–F23.
2. Centers for Disease Control and Prevention. Number of HPV associated cancer cases per year. Available at: https://www.cdc.gov/cancer/hpv/statistics/cases.htm. Accessed August 10, 2017.
3. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015; 107: djv086.
4. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(suppl 5): F123–F138.
5. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014; 63:1–30.
6. Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015; 64:300–304.
7. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56:1–24.
8. Kroger AT, Atkinson WL, Marcuse EK, et al., Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) (errata in: 2006; 55:1303, Pediatrics 2007;119:1008 and 2007;56:256). MMWR Recomm Rep. 2006; 55:1–48.
9. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep.

Dr. Susana Trujillo
Dr. Susana Trujillo
2134788815
email us here

Fucoidan 3-Plus contains high-purity Fucoidan!


Source: EIN Presswire

Invitation from James Drinkwater Chairing The 2nd Annual Pharmaceutical Microbiology East Coast Conference


The 2nd Annual Pharmaceutical Microbiology East Coast conference is returning to the Battery Wharf Hotel, Boston, USA on April 10th and 11th, 2019

BOSTON, MA, UNITED STATES , November 30, 2018 /EINPresswire.com/ — The two-day conference will be discussing best practices and techniques to tackle microbial control challenges within the pharmaceutical microbiology industry.

The Chair for the event was recently announced to be James Drinkwater, Chairman at PHSS and Head of Aseptic Processing Technologies & GMP Compliance, Franz Ziel GmbH

James currently holds the position of Chairman for the Pharmaceutical and Healthcare Sciences Society (PHSS) and lead the PHSS Annex 1 focus group from which 100 pages of comments were provided to the EMA during the revision consultation process. Also as part of the UK delegation from UCL: University College London, to provide Jordanian and Saudi Arabia FDA inspectors training on Quality assurance sterile product manufacturing including environmental control and monitoring for aseptic processing, and he is aware of current challenges and knowledge gaps for both the industry in regulators.

Mr Drinkwater says “As conference chair for the 2nd Annual Pharmaceutical Microbiology East Coast event in Boston, it would be my pleasure to invite you to attend this meeting on April 10th and 11th 2019.
Pharmaceutical Microbiology is a constant within all areas of pharmaceutical manufacturing and the field has been undergoing a period of vast change. With advances in rapid microbial methods, changes to regulations, our increasing knowledge of the human microbiome and new testing methods, the implementation of new strategies for contamination control and applying quality risk management (QRM) are challenging us all.

The Pharmaceutical Microbiology East Coast Conference will include presentations from colleagues with expertise in the following emerging disciplines:

• Science and regulation: preparing suitable contamination control strategies and ensuring CGMP compliance. Including a keynote session on considered impact from revision on Annex 1 on a new Aseptic processing Filling line to provide an insight to attendees of preparation for this upcoming major revision in GMP requirements for future projects.
• Rapid microbial methods, both implementation and an industry perspective on process automation
• Quality control considerations in microbial therapies and mycoplasma testing

Please download the brochure from the website for the full list of speakers and 2-day programme.

The 2019 agenda for the event is packed with hot topics, such as revision of Annex 1, contamination control, regulations of endotoxin detection methods and control, environmental monitoring, rapid microbial methods, sterility assurance, mold isolation, risk mitigation for mycoplasma, animal sera and much more.

For the full agenda and speaker line-up, visit the website to download the brochure at:
www.microbiologyeastcoast.com/PR1

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
Pharmaceutical Microbiology East Coast
April, 10 & 11, 2019
Battery Wharf Hotel, Boston, USA
www.microbiologyeastcoast.com/PR1

Follow us @SMiPharm
#SMiPharmaMicroEC

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+442078276000
email us here


Source: EIN Presswire

Revolutionary business management app for the mobile service industry takes the market by storm.

The admin dashboard and views of the app on different devices as different workers

The Day Pilot view gives users automatic route optimisation and navigation

Billing and payments made easy with stripe and GoCardless fully integrated

Squeegee – the must have companion for any size and type of mobile service business

My work/life balance has improved tenfold. What used to be a 20-30 min chore to complete the “end of day” admin has now shrunk to about 2-3 minutes. Simply put you shouldn’t be using anything else.”

— Chris Rose of C.Rose cleaning services

HEREFORD, HEREFORDSHIRE, UNITED KINGDOM, November 30, 2018 /EINPresswire.com/ —
WHAT IS SQUEEGEE?

Squeegee is an established scheduling system that is fast becoming the market lead among SMEs wanting to optimise efficiency in their business. It has been designed to manage the entire workflow for businesses in the service industry, which started with an app initially designed for window cleaners managing their work: from easy entry of customer details, to the intricacies of scheduling work and managing payments. In partnership with a group of beta users in many different industries, the team employed a strong user feedback model to ensure that the product was shaped with the user at its core. Now with the addition of the newly launched Enterprise plan, Squeegee caters for teams of any size, allowing work assignment and a complete suite of features that give oversight of the business in real time.

The creators of the system, Nexdynamic, have a strong background in innovation in development, and in seeing the types of software on offer for small businesses that were old fashioned and pricey, saw that there was an opportunity to create something new that would benefit everyone. Using only the latest technology and architecture, Squeegee was born from this ideal of improving the workflow of SMEs whilst remaining true to the ethos of being driven by the user, not money. A huge amount of research into the tasks that service providers complete as a part of their daily workflow was part of the upfront work, as well as ensuring the infrastructure that the platform was built on was robust and infallible allowing users to sit back knowing their data is not only safe, but backed up and easily restored in the event of it needing to be.

SO WHAT DOES IT DO AND HOW DOES IT DIFFER FROM OTHER SCHEDULING SOFTWARE ON THE MARKET?

Squeegee was always designed to be fully mobile from the very beginning. The intention was to improve workflow by ensuring tasks that can be completed out in the field have the simplest possible solution, vastly reducing time spent on administrative tasks.

Squeegee takes control of customer management, job scheduling, billing and payments, route optimisation and navigation, business expenses and has accountancy features all included. Although some of the features mentioned can be seen in the product descriptions of many pieces of software, Squeegee is unique in the way that all data is synced in real time, meaning that everyone has access to everything they need, exactly when it’s needed.

WHO IS IT FOR?

Squeegee is for everyone from new start-ups, through to established multinational corporations. The plans that are available mean it is accessible to everyone from the standard plan for one user who is starting out, the premium plan for sole traders needing end to end business management, and the enterprise plan for anyone working in teams of any size with specific roles and permissions set on each account.

FEATURES

Squeegee is feature rich and complex in functionality whilst being the most user friendly piece of software on the market.

SCHEDULING
Squeegee keeps scheduling simple. Schedule one off or recurring appointments in a matter of seconds, with any frequency. Complete, skip or replan appointments with a swipe or update the whole schedule on individual jobs or an entire day’s work in one go.

GROUP SCHEDULING BY ROUNDS
Scheduling by rounds allows users to set a job location and frequency for all jobs within a group and for these to be updated in one step. The order of jobs can be set within rounds so that when rounds are assigned to users and are seen on their work planner or Day pilot for navigation, they retain the same order every time.

ASSIGNING WORK
Each user has their own role and set of permissions created by an admin, and work can either be assigned to them as a default if they carry out the same work each week/month etc, or on a job by job basis.

NAVIGATING WITH ROUTE OPTIMISATION
The revolutionary Day Pilot feature not only provides navigation from job to job, but optimises routes using real time traffic data giving the option to update when a better route is found. If jobs need to be done in a particular order on a day or round, this is also an option and Day Pilot will purely navigate between jobs and display the expected overall time for the whole day’s work.

INVOICING AND PAYMENTS
Most Squeegee users enjoy setting up their accounts with automatic invoicing on job completion and many choose to also have these automatically sent to their customers via email of SMS all in the one swipe! Customers can pay manually, online directly from the invoice using Stripe, or can be set up with Direct Debit payments using GoCardless.

EXPENSES
Expenses can be managed on the move and easily sorted by category which can be visual using emojis and images to help. All entered expenses can then be used to form different profit and loss reports against payments and invoices. Very soon, receipts will be able to be captured and stored against expenses too in order to make sure the papertrail is kept in one place.

INSIGHTS AND REPORTS
Insights give a monthly snapshot into customers, jobs and financials showing some key headline figures and trends. There are a number of available reports in the reports tab which can be downloaded at any time.

ADMIN OVERVIEW
The admin overview gives a snapshot into real time progress of workers including location, completed jobs, those invoiced and those that have made a payment, all at a glance. This real time data is invaluable for businesses for administrators to step in, quickly and easily reassign work when needed and ensure all work planned is completed each day.

GROWTH

Squeegee’s growth has been building in momentum from day one, to now becoming one of the fastest growing work scheduling and management systems with unparalleled customer service and support. Squeegee’s usage is doubling every two weeks, with thousands of customers all across the Globe.

Susie Bishop
Squeegee
+44 330 900 4040
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Microscopy Devices Market Size, Share & Trend | Global Industry Report, 2018-2023

Microscopy Market By Product, By Type, By Application, By End User, By Region – Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Companies are increasingly focusing on the expansion of the scope of Microscopy”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, November 30, 2018 /EINPresswire.com/ — Overview
Microscopy is the specific field of employing microscopes to see particles that can't be seen with the naked eye and the objects that are not inside the determination scope of the ordinary eye. The development of microscopy has changed the field of biology, gave rise to the field of histology and continues to be an essential technique in the life sciences Industry.

The Global Microscopy Market was worth USD 6.52 billion in 2018 and estimated to reach USD 8.73 billion by 2023, increasing at a CAGR of 6%.

Increasing adoption of advanced magnifying devices and a growing spotlight on nanotechnology and regenerative medicine are some of the major factors contributing to the growth of the market. The subsidization situation is also highly positive in this field. Companies are increasingly focusing on expanding the application scope of microscopy, which would help in driving the future growth of the market.

View sample and decide: https://marketdataforecast.com/market-reports/microscopy-market-7979/request-sample

Presently, automation and artificial intelligence in magnified imaging equipment are some of the key interest factors in the market. Firms such as Carl Zeiss and Olympus Corporation are concentrating on assimilating microscopes with automated platforms to widen their application scope in the life sciences and material sciences industry. Rising utilization of such devices can potentially enhance operational productivity in numerous establishments such as hospitals and manufacturing units.
Another vital use of microscopes can be found in surgical interventions. Surgical techniques related to cancers and neurosciences have great demand for magnified imaging systems so as to boost the procedural success. Key market players are focusing on the development of dedicated product offerings related to microsurgeries (spine, cranial, and other multi-disciplinary surgeries). These devices are classified as class I medical devices and can easily gain approval for commercialization.

To know more read: https://marketdataforecast.com/market-reports/microscopy-market-7979/

The complete report for the global Microscopy market provides all the information required for the decision making and investing opportunities based on the market size, revenue, history, current trends and future predictions. It also provides the deep sights of the global market based on the product, type, application, end-user and regional analysis, along with the competitive landscape.

On the basis of product, the market is separated into
• Microscopes
• Accessories

Microscope segment grabs the major portion of the global market in terms of revenue.

On the basis of type, the market is separated into
• Optical Microscope
• Electron Microscope
• AFM (Atomic force microscopy)
• STM (Scanning tunnelling microscope)
• NSOM (Near-field scanning optical microscope)

Optical microscope segment is estimated to lead the market and is projected to maintain its dominance during the forecast period. Scanning tunnelling microscope is an advanced technique and has considerable growth potential over the next decade.

On the basis of application, the market is separated into
• Semiconductor
• Nanotechnology
• Electronics

Nanotechnology is a high growth opportunity segment and is being increasingly targeted by companies.

On the basis of an end user, the market is separated into
• Industrial
• Research institution
• Blood banks

On the basis of the regional analysis, the market is separated into
• North America
• Europe
• Latin America
• Middle East and Africa
• Asia Pacific

North America recorded the highest share for the microscopy market, closely trailed by Europe and this trend is expected to continue over the next few years. The high potential for growth in emerging countries of the Asia Pacific and Latin America is anticipated to interest key players operating in the microscopy market in the next decade.

Get your customized report: https://marketdataforecast.com/market-reports/microscopy-market-7979/customize-report

Some of the top players in the global market include Carl Zeiss, Danaher, Thermo Fisher, Nikon, Bruker Corporation, Olympus, Oxford Instruments, JEOL, and Hitachi High-Technologies, Keyence, Vision Engineering, and Helmut Hund.

The scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• A segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Related research study download free sample @ Tumor Ablation Market, Pyrethroid Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

MAHANTH
Market Data Forecast
+1-888-702-9626
email us here


Source: EIN Presswire

Microbiome Sequencing Services Market | Industry Share and Market Outlook, 2023

Microbiome Sequencing Services Market By Technology, By Application, By Research Type, By Laboratory Type, By End User, & By Region (2018-2023)

New high-throughput sequencing and innovative software tools are transforming the field of microbiome study”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, November 30, 2018 /EINPresswire.com/ — Microbiome sequencing is the study of microbial groups located within the human body. The aim of human microbiome research is to properly understand the role of microbes in health and disease. Previously, scrutinizing samples from human skin, stool, or blood was reliant on time and labour-intensive microbiology techniques (on the rise and isolating individual organisms followed by phenotypic or genotypic analysis). However, the onset of next-generation sequencing (NGS) has facilitated numerous high-profile collaborative projects (Human Microbiome Project and MetaHIT). A broad range of data on the subject of human microbiome was published, employing NGS as a foundational tool.
The sequencing of metagenome offers a unique technique in identifying and treating a broad range of chronic ailments. Internationally, governments are investing a significant amount of money into microbiome sequencing projects. In 2007, the US National Institutes of Health financed USD 140 million to the Human Microbiome Project (a study of all the microorganisms in the human body). In 2008, the European Commission funded USD 30 million for Metagenomics of the Human Intestinal Tract project (MetaHIT).

The Global Microbiome Sequencing Services Market as per Market Data Forecast, Inc. report is predicted to reach USD 1,914.6 Million by 2023 with a CAGR of 21.5% from the current value of USD 722.9 Million.

Request for sample: https://marketdataforecast.com/market-reports/microbiome-sequencing-services-market-7992/request-sample

The primary factor contributing to the growth of the microbiome sequencing services market development in the mounting utilization of microbiomes in genomics, proteomics, and metabolomics. New high-throughput sequencing and innovative software tools are transforming the field of microbiome study. Human microbiome sequencing services would be of great help in the commercialization of personalized medicine and diet.

However, lack of proper specialists in the interpretation of sequencing information is the key factor hampering the growth of the microbiome sequencing services market. Microbiome sequencing produces a gigantic amount of data, which needs to be deduced correctly. Lack of awareness and knowledge of advanced tools of data analysis is a huge problem and must be tackled effectively. Additionally, government regulations and ethical & legal issues connected to NGS are curbing the growth of the microbiome sequencing services market.

Get full report @ https://marketdataforecast.com/market-reports/microbiome-sequencing-services-market-7992/

The full report provides a deep insight into the global market of microbiome sequencing services including its share, size, trends, analysis, and forecast along with the accurate information of its regional presence and competitive landscape. The global microbiome sequencing services market is divided on the basis of technology, application, research type, laboratory type, end user, and geographical regions.
Based on technology, the sequencing by synthesis segment is expected to account for the largest share of the market. It is an extensively employed NGS method, responsible for generating more than 75% of the sequencing data globally.

Based on the application, the RNA sequencing segment has been increasing rapidly with the highest CAGR due to major recent developments. The development of Oligo Library Synthesis kit for RNA libraries, permitting m-RNA targeted sequencing is anticipated to further drive the market growth in the near future.

Based on research type, the outsourced research segment is expected to grab a major portion of the market, whereas, under the “laboratory type” category, the wet labs’ segment is expected to lead the microbiome sequencing services market.

Under the end user category, pharmaceutical and biotechnology firms combinedly account for more than 50% of the overall market share. Numerous well-known pharmaceutical businesses are expanding their focus on microbiome R&D, thereby boosting the market revenue and growth.

Based on the geographical distribution, the international market is divided into the regions of North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is presently leading the overall market, primarily due to factors, such as government backing through funds for genomics research, regular developments in sequencing technologies, and ease in accessibility of commercial product solutions for NGS data analysis. On the other hand, Asia-Pacific is anticipated to grow exceedingly during the forecast period. The steady development of the biotech industry in Southeast Asia is going to be a crucial growth prospect for the microbiome sequencing services market.

Customized report: https://marketdataforecast.com/market-reports/microbiome-sequencing-services-market-7992/customize-report

The global microbiome sequencing services market is in all probability going to stay divided in the coming few years due to the accessibility of several open doors in the market for players of all size. The major players in the global microbiome sequencing services market include Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.

Scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the untapped regions.
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Related research study download free sample @ X-Ray Detectors Market, Antacid Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here


Source: EIN Presswire

Hospital Lighting System Market | Industry Share and Market Outlook, 2023

Hospital Lighting Market By Technology, By Application, Product, By Region – Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Advancing science and technology enables the manufacturers to prepare hospital lights with tailored requirements for specific purposes”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, November 30, 2018 /EINPresswire.com/ — Well-designed patient room lighting plays an important role for the diagnosis of the patient and improve patient outcomes. Ideal hospital lighting systems give patients more control of their environment while helping caregivers do their jobs more effectively. Different types of lighting devices include hospital bed lighting, task lighting and general ambient lighting. Hospital Lights are the kind of lights used in hospital rooms like patient wards, Intensive Care Units (ICUs) and surgical suites. The lighting in hospitals is different to lighting in general, as the hospital lighting is required to be of just sufficient intensity and brightness, not less and not more.

The Hospital Lighting Market has been valued at USD 7.55 billion in 2018 and is projected to reach approximately USD 10.25 billion by 2023, at a CAGR of 6.3%.

Medical facilities gain a healthier diagnosis with a dose of LED lighting. This technology delivers clean, bright light and accurate color to assist diagnosis and treatment and create a tranquil environment. Outside, these devices provide parking structures and exterior grounds enhanced safety and security. They require virtually no maintenance for decades, cut energy costs by as much as 80 %, and eliminate the toxic wastes of fluorescents and CFLs.

View sample and decide: https://marketdataforecast.com/market-reports/hospital-lighting-market-8151/request-sample

The modernization of hospitals in developed regions like Europe and North America, increasing preference toward LED lights from the conventional fluorescent lights are the significant drivers behind the high estimated growth of the industry. Rapidly advancing science and technology enables the manufacturers to prepare hospital lights with tailored requirements for specific purposes. Others factors include enhanced shelf life of merchandise, increase in investments in healthcare sector, growing number of patients and rise in global aging population is driving the market.

However unstable reimbursement regulations, high cost of devices and economic instability are the major factors hindering the growth of the market.

To know more read: https://marketdataforecast.com/market-reports/hospital-lighting-market-8151/

The full report provides the complete information about the Hospital Lighting Market and describes the overall market size, share, trends and future analysis. It also provides the in-depth knowledge by explaining the market based on the products, technology, application and regional distribution.

Based on the Technology, the market is divided into Renewable energy, LED and Fluorescent lights. LED segment of the market is expected to lead the market till 2023, owing to the increased usage of LED lights globally. As per Application, the market is classified as the following – Surgical suites, Patient wards & ICUs and Examination Rooms. In 2018, the market was dominated by the Patient wards & ICUs segment. Regulations necessitating a better level of infrastructure in ICUs around the world is the key reason behind this market trend. According to product, the market is categorized into Surface Lamps, Troffers, and Surgical Lamps. Troffers segment of the market is to lead the market in the forecast period, according to the market share.

Under region, the global market is analyzed as the following regions – North America, Latin America, Europe, Asia Pacific and Middle East and Africa. North America region occupied the top position among all the regions in terms of market share, because of the extensive well-established hospitals in the region. The increasing healthcare services in emerging countries like India and China, the Asia-Pacific region provides largely untapped market potential for the future.

Get your customized report: https://marketdataforecast.com/market-reports/hospital-lighting-market-8151/customize-report

The report also offers the information about the competitive landscape of the region, which include key market players in present day like General Electric Company, Eaton Corporation PLC, Cree Inc., Zumtobel Group AG, KLS Martin GmbH + Co. KG, Koninklijke Philips N.V., Herbert Waldmann GmbH & Co. KG, Trilux GmbH & Co. Kg, Hill-Rom Holdings Inc. and Acuity Brands.

Scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Related research study download free sample @ Hospital Supplies Market, Single Use Medical Device Reprocessing Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here


Source: EIN Presswire

Vital Signs Monitoring Devices Market Size, 2018 – 2023

Increasing adoption of advanced magnifying devices and growing spotlight on nano technology is major contributor of the market

Upsurge of population and many unexplored markets, are the secondary factors driving the growth of this market”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, November 30, 2018 /EINPresswire.com/ — Vital signs are measurements of the body's most basic functions. The four main vital signs are Body temperature, Pulse rate, Respiration rate (rate of breathing) and Blood pressure (Blood pressure is not considered a vital sign, but is often measured along with the vital signs. These are routinely monitored by medical professionals and health care providers with Vital signs monitoring devices. They help in early diagnosis of a chronic disease.

The market analysis predicts that Vital Signs Monitoring Market with a CAGR of 6.7% is aimed to reach USD 6.04 billion by 2023, which valued at USD 4.37 million by the end of 2018.

Vital signs can be measured at home, in a medical setting, at the site of a medical emergency, or any other place. The normal ranges for a person’s vital signs vary with gender, weight, age and overall health condition.

View Sample Report: https://marketdataforecast.com/market-reports/vital-signs-monitoring-market-8224/request-sample

The Vital signs Monitoring Market is primarily driven by the entry of a lot of innovative products, paradigm shift towards home healthcare services, increasing instances of chronic diseases. Augmenting geriatric population, greater market penetration of insurance companies, and medical tourism on the rise in the emerging economies, increased adoption of the process by customers in clinical diagnosis, demand for personalized healthcare, upsurge of population and many unexplored markets, are the secondary factors driving the growth of this market.

However, the lack of proper infrastructure, insufficient government aid, scarcity of market professionals, accurate analysis of the end data, and other few elements may control the exponential growth of the Global Vital Signs Monitoring Markets.

Get Full Report: https://marketdataforecast.com/market-reports/vital-signs-monitoring-market-8224/

You can have a better picture of the global markets with our full report and it provides the acumen in key areas helpful in future planning. As per our report, the global Vital Signs Monitoring Market is categorized on the basis of product, end user and geographical regions.

On the basis of product, the market is separated into
• BP monitoring devices
• Pulse-oximeters
• Temperature monitoring devices

Pulse oximeters are the market leader by product and are expected to remain so in the aforementioned forecast period. Increasing demand in emergency medical care is the reason behind this trend.

On the basis of end user, the market is separated into
• Hospitals
• Physician’s Office
• Home Healthcare
• Ambulatory Centers
• Emergency Care Centers
• Other Healthcare Settings

In 2018, the end user hospitals segment captured the largest market share holds the major market revenue and estimated to continue the similar trend for coming years.

On the basis of regional distribution, the market is separated into
• North America
• Asia Pacific
• Latin America
• Europe
• Middle East & Africa

North America is the largest regional market. Augmenting geriatric population, increasing cases of interminable disorders etc. are the reasons attributable to the observable trend mentioned above. Europe accounted for the second largest market share. Increasing death rate and rising demand for cost effective treatment are the reasons behind this trend. Asia Pacific is anticipated to be the fastest growing market in the aforementioned forecast period. Extensive unmet needs especially primary healthcare the reasons behind this. Furthermore, increased medical tourism in this region is attracting a lot of market players for investment in this part of the world.

Get Customized report: https://marketdataforecast.com/market-reports/vital-signs-monitoring-market-8224/customize-report

Key players in the market are
• Koninklijke Philips N.V.
• Medtronic
• Nihon Kohden Corporation
• GE Healthcare
• Masimo
• Omron Healthcare

Other players in the market include Contec Medical Systems Co. Ltd, A&D Company Ltd., Nonin Medical Inc., and SunTech Medical, Inc.

Scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Related research study download free sample @ Cell Signaling Market, Medical Robots Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here


Source: EIN Presswire